Literature DB >> 18042342

Inhibition of message for FcepsilonRI alpha chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae.

Danlin Luo1, Yuling Dai, Lynn B Duffy, T Prescott Atkinson.   

Abstract

We have previously described the activation of RBL-2H3 mast cells for IL-4 production by Mycoplasma pneumoniae but the mechanism remains unclear. M. pneumoniae binds eukaryotic cells primarily through sialoglycoproteins on the target cell surface. This study was undertaken to determine whether the sialated FcepsilonRI alpha chain on RBL cells is important for M. pneumoniae-induced IL-4 production. We found that IgE-mediated IL-4 release by a series of RBL sublines correlated with the release induced by M. pneumoniae. Further, aggregation of FcgammaRII (CD32) in RBL cells using a monoclonal antibody inhibited both IgE-mediated and mycoplasma-induced IL-4 production, providing further evidence for an Fc receptor-mediated mechanism of activation. To examine the role of FcepsilonRI in mycoplasma-induced IL-4 release, we created stably transfected RBL sublines using a vector expressing a short hairpin sequence designed to inhibit message for the FcepsilonRI alpha chain. IgE-induced IL-4 production by the transfected sublines was reduced in similar proportion to the degree of message suppression. M. pneumoniae-induced IL-4 production in the four transfected sublines was completely blocked in contrast to results with the controls or parent RBL cells. We conclude that the heavily glycosylated FcepsilonRI alpha chain is required for activation of mast cells for IL-4 production by M. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042342      PMCID: PMC2408751          DOI: 10.1016/j.micpath.2007.10.008

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  39 in total

1.  Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells.

Authors:  A Yavlovich; M Tarshis; S Rottem
Journal:  FEMS Microbiol Lett       Date:  2004-04-15       Impact factor: 2.742

2.  Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Deborah F Talkington
Journal:  Microb Pathog       Date:  2003-01       Impact factor: 3.738

3.  Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma.

Authors:  Aydanur Ekici; Mehmet Ekici; A Kemal Erdemoğlu
Journal:  J Asthma       Date:  2002-04       Impact factor: 2.515

4.  Induction of regulated upon activation, normal T cells expressed and secreted (RANTES) and transforming growth factor-beta 1 in airway epithelial cells by Mycoplasma pneumoniae.

Authors:  Azzeddine Dakhama; Monica Kraft; Richard J Martin; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-24       Impact factor: 6.914

5.  Release of cytokines by human nasal epithelial cells and peripheral blood mononuclear cells infected with Mycoplasma pneumoniae.

Authors:  Mikhail Y Kazachkov; P C Hu; Johnny L Carson; Paula C Murphy; Frederick W Henderson; Terry L Noah
Journal:  Exp Biol Med (Maywood)       Date:  2002-05

6.  Mycoplasma pneumoniae and asthma in children.

Authors:  Sandra Biscardi; Mathie Lorrot; Elizabeth Marc; Florence Moulin; Benedicte Boutonnat-Faucher; Claire Heilbronner; Jean-Luc Iniguez; Michèle Chaussain; Elizabeth Nicand; Josette Raymond; Dominique Gendrel
Journal:  Clin Infect Dis       Date:  2004-04-29       Impact factor: 9.079

Review 7.  Negative regulation of mast cell proliferation by FcgammaRIIB.

Authors:  Odile Malbec; Jean-Pierre Attal; Wolf H Fridman; Marc Daëron
Journal:  Mol Immunol       Date:  2002-09       Impact factor: 4.407

8.  Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen.

Authors:  María A Meseguer; Alberto Alvarez; María T Rejas; Carlos Sánchez; José C Pérez-Díaz; Fernando Baquero
Journal:  Infect Genet Evol       Date:  2003-05       Impact factor: 3.342

9.  Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Deborah F Talkington
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.

Authors:  Monica Kraft; Gail H Cassell; Juno Pak; Richard J Martin
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

View more
  1 in total

Review 1.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.